Unibest

Pharmaceutical intermediates

Dexmedetomidine Hydrochloride Intermediates

1 pharmaceutical intermediate for Dexmedetomidine Hydrochloride. Indication: Sedation.

提交项目All intermediates

About Dexmedetomidine Hydrochloride

Originator
Orion Corporation
Indication
Sedation
Approved Date
12/17/1999
DS/DP
01/04/2032

Available intermediates

1 intermediate currently listed for Dexmedetomidine Hydrochloride. Request specifications, documentation or a quotation for any item below.

Dexmedetomidine Hydrochloride intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
1-Tritylimidazole-4-carboxaldehyde33016-47-6//

Other programs under D

Dabigatran EtexilateDabigatran etexilate mesylateDabrafenib MesylateDacomitinibDanicopanDapagliflozinDaridorexant HydrochlorideDarolutamide

Building toward Dexmedetomidine Hydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →